Aurora Cannabis (ACB) Cash & Equivalents (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash & Equivalents of $47.2 million for Q1 2026, down 50.92% year-over-year from $96.1 million in Q1 2025, and up 16.71% quarter-over-quarter from $40.4 million in Q4 2025.
Aurora Cannabis (ACB) Cash & Equivalents (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash & Equivalents for 9 consecutive years, with $47.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 50.92% year-over-year to $47.2 million; the TTM figure through Mar 2026 stood at $47.2 million (down 50.92% YoY), while the FY2026 annual figure was $47.2 million, down 52.45% from the prior year.
- Cash & Equivalents advanced to $47.2 million in Q1 2026 per ACB's latest filing, from $40.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $343.4 million in Q2 2022 and bottomed at $40.4 million in Q4 2025.
- Historically, Cash & Equivalents has averaged $140.9 million across 5 years, with a median of $101.1 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Equivalents advanced 0.15% — and 2023, when it tumbled 66.04%.
- Aurora Cannabis' Cash & Equivalents stood at $190.6 million in 2022, then sank by 44.36% to $106.0 million in 2023, then decreased by 10.47% to $94.9 million in 2024, then tumbled by 57.43% to $40.4 million in 2025, then climbed by 16.71% to $47.2 million in 2026.
- Business Quant data shows ACB's Cash & Equivalents at $47.2 million in Q1 2026, $40.4 million in Q4 2025, and $69.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 50.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.17 Mn |
| Dec 31, 2025 | 40.42 Mn |
| Sep 30, 2025 | 69.53 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 96.12 Mn |
| Dec 31, 2024 | 94.94 Mn |
| Sep 30, 2024 | 78.85 Mn |
| Jun 30, 2024 | 101.05 Mn |
| Mar 31, 2024 | 101.00 Mn |
| Dec 31, 2023 | 106.04 Mn |
| Sep 30, 2023 | 96.16 Mn |
| Jun 30, 2023 | 117.52 Mn |
| Mar 31, 2023 | 189.06 Mn |
| Dec 31, 2022 | 190.59 Mn |
| Sep 30, 2022 | 283.14 Mn |
| Jun 30, 2022 | 343.39 Mn |
| Mar 31, 2022 | 339.39 Mn |
| Dec 31, 2021 | 263.71 Mn |
| Sep 30, 2021 | 296.15 Mn |
| Jun 30, 2021 | 342.87 Mn |